About

Know me!

Dr. Cécile Philippe completed her PhD in 2017 at Université de Bordeaux (France), focusing on interactions between phages and lactic acid bacteria in wine. Following her doctoral studies, she conducted research on phages infecting Streptococcus thermophilus in the lab of Sylvain Moineau at Université Laval (Québec, Canada). During this period, she gained expertise in using CRISPR-Cas9 for phage genome engineering and studied CRISPR and anti-CRISPR systems for three years. Her investigations into these topics continued in Michael Terns' lab at the University of Georgia (USA). In 2022, Dr. Philippe joined Sarah Satola’s lab at Emory University (USA) and the Investigational Clinical Microbiology Core, where she received training in the epidemiology of multi-drug-resistant healthcare-associated infections under the guidance of Dr. Ahmed Babiker and Michael Woodworth. In 2023, Dr. Philippe became a permanent researcher at the French Research Institute for Exploitation of the Sea (Ifremer). Her primary research interest is the molecular epidemiology of pathogenic bacteria contaminating shellfish and the role of mobile genetic elements in their persistence within a One Health context.